Characterization of effusion-infiltrating T cells: benign versus malignant effusions.
about
Comparative Gene Expression Analysis of Lymphocytes Treated with Exosomes Derived from Ovarian Cancer and Ovarian Cysts.What's the place of immunotherapy in malignant mesothelioma treatments?Defect in recruiting effector memory CD8+ T-cells in malignant pleural effusions compared to normal pleural fluid.CD39+ regulatory T cells suppress generation and differentiation of Th17 cells in human malignant pleural effusion via a LAP-dependent mechanismTargeting miR-23a in CD8+ cytotoxic T lymphocytes prevents tumor-dependent immunosuppression.Immunological milieu in the peritoneal cavity at laparotomy for gastric cancerProphylactic and therapeutic implications of toll-like receptor ligands.Tumor-induced CD8+ T-cell dysfunction in lung cancer patients.Targeting the immune system in the treatment of non-small-cell lung cancer.The PD-L1/PD-1 pathway promotes dysfunction, but not "exhaustion", in tumor-responding T cells from pleural effusions in lung cancer patients.Analysis of Lymphocyte Immunological Reactivity in Patients with Pleural Effusions of Different Aetiology.Immunological Analysis and Generation of Dendritic Cells From Lavage Fluid Obtained by Cell-Free and Concentrated Ascites Reinfusion Therapy.Patients with solid tumors treated with high-temperature whole body hyperthermia show a redistribution of naive/memory T-cell subtypes.Activation-induced cell death of memory CD8+ T cells from pleural effusion of lung cancer patients is mediated by the type II Fas-induced apoptotic pathway.
P2860
Q33747629-3BBC8717-0BC1-4FD3-BE71-1DE1921B524FQ33781142-7610A3EB-7CF9-4995-8410-78DAD58F4AF3Q34788477-4BC35E4A-8ED5-45E1-98F6-D98B414398F1Q35061140-8368B68D-FA95-46F8-90B4-17FD589F6D92Q35145392-F9D6BBFB-62B1-4237-934F-2809E49EB6D0Q35872049-BD23A51B-DABC-43CA-A4A1-4EC604CA25EFQ37989884-B45D2AF2-94EE-40E9-AB14-6C6206DBEB77Q38057233-FCBDE333-3CC8-40B1-8646-E3D1FD1D9EC6Q38128228-1FCB5E26-5B41-405F-A48D-2EE2981C6BC5Q38910078-3F7E0B7E-42B9-4E62-A833-1ACBD2737E4BQ42754236-6A0782F8-F9BA-4C37-860C-B7C48B83BBCCQ45869272-8364DB0F-D5A3-4FBF-BF6D-224B9BC4DCBAQ46778114-E1714711-7E4C-450B-8EED-2D07028A1D72Q50978684-0F6C0763-3120-4FC3-9305-7152983347A7
P2860
Characterization of effusion-infiltrating T cells: benign versus malignant effusions.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Characterization of effusion-infiltrating T cells: benign versus malignant effusions.
@en
Characterization of effusion-infiltrating T cells: benign versus malignant effusions.
@nl
type
label
Characterization of effusion-infiltrating T cells: benign versus malignant effusions.
@en
Characterization of effusion-infiltrating T cells: benign versus malignant effusions.
@nl
prefLabel
Characterization of effusion-infiltrating T cells: benign versus malignant effusions.
@en
Characterization of effusion-infiltrating T cells: benign versus malignant effusions.
@nl
P2093
P1476
Characterization of effusion-infiltrating T cells: benign versus malignant effusions.
@en
P2093
Andreas Block
Andreas de Weerth
Christiane Faltz
Dieter Kurt Hossfeld
Djordje Atanackovic
Susanna Hegewisch-Becker
P304
P356
10.1158/1078-0432.CCR-03-0239
P407
P577
2004-04-01T00:00:00Z